title: Exacerbation of psoriasis vulgaris during nivolumab for oral mucosal melanoma.
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kato
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan. otsukamn@kuhp.kyoto-u.ac.jp.
authors.forename: A
authors.initials: A
authors.lastname: Otsuka
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Miyachi
authors.affiliation: Department of Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan. kaba@kuhp.kyoto-u.ac.jp.
authors.forename: K
authors.initials: K
authors.lastname: Kabashima
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D009062:Mouth Neoplasms / Q000188:drug therapy*; D000077594:Nivolumab; D011565:Psoriasis / Q000139:chemically induced*
chemical_list: D000911:Antibodies, Monoclonal; D000077594:Nivolumab